Crossmark

Prognostic stratification with composite insulin resistance–inflammation biomarkers in patients with chronic kidney disease and coronary artery disease across glycemic statuses

Crossref DOI link: https://doi.org/10.1186/s12933-026-03108-0

Published Online: 2026-03-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ye, Zixiang

Xie, Enmin

Song, Chenxi

Zhang, Rui

Wang, Haoyu

Wu, Chao

Dou, Kefei
License Information

Text and Data Mining valid from 2026-03-02

Version of Record valid from 2026-03-26
More Information

Article History

Received: 29 December 2025

Accepted: 2 February 2026

First Online: 2 March 2026

Declarations

:

: The research adhered to the ethical principles outlined in the Declaration of Helsinki and received approval from the CDC’s institutional review board.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below